Skip to content

Navicam for Detection of Barrett's Esophagus

Use of a Detachable String Capsule for Evaluation of Barrett's Esophagus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06748911
Acronym
DS-MCE-BE
Enrollment
57
Registered
2024-12-27
Start date
2025-02-20
Completion date
2026-09-30
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's Esophagus

Brief summary

Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus

Interventions

DEVICENaviCam Detachable String Capsule

Subjects will swallow the NaviCam capsule with 20 ml water while positioned in the upright position. Once the capsule reaches the gastric cardia, the string will slowly be pulled up to systematically inspect the Z-line and upper, middle, and lower thirds of the esophagus guided by real-time viewing and by moving the capsule solely with the tether. Images will be captured at a rate of 2 frames per second.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults greater than or equal to 22 years of age with or without Barrett's Esophagus * All Patients: o Have had an endoscopy within 1 year of baseline enrollment * Patients with Barrett's Esophagus: * Presence of at least 1cm of salmon colored mucosa with corresponding biopsies showing intestinal metaplasia who are treatment naïve and undergoing surveillance Or * Chronic Gastro Esophageal Reflux Disease (GERD) patients with at least 3 additional risk factors that meet Barrett's Esophagus screening criteria per latest clinical guidelines

Exclusion criteria

* Inability to comprehend or read the consent form * Have an oropharynx, esophageal, or gastro-esophageal tumor * Ongoing symptoms of dysphagia * Presence of active clinically significant stricture * History of stricture requiring dilation * Presence of pacemaker or implanted cardiac defibrillator * History of esophageal surgery with the exception of fundoplication * Pregnancy * History of surgery or obstructive process of the small bowel * BMI \> 38

Design outcomes

Primary

MeasureTime frameDescription
Detection of Columnar lined epithelium in the esophagusFrom start of procedure to removal of capsule, assessed up to 30 minutes timeframe from start to end of procedure..Detection of Columnar lined epithelium in the esophagus

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)30 minutes post-procedureVisual Analogue Scale (VAS) is an 11-tem questionnaire assessing pain, where 0 represents the "worst experience" and 10 the "best experience". Total scores range from 0 - 110, lower scores indicating lower pain and higher scores indicating greater pain.
Spielberger State-Trait Anxiety Inventory (STAI-6)Baseline, 30 minutes post-procedurePatient anxiety will be measured using the shorter 6 item form of the Spielberger State-Trait Anxiety Inventory (STAI-6), with a score over 40 as a threshold for clinically significant anxiety
Impact of Events Scale (IES)Baseline, 7 days post-procedureThe Impact of Events Scale (IES) will be used to assess distress associated with the procedure and procedure acceptability. The IES is rated on a scale of 0 (not at all) to 4 (extremely), with higher scores indicating a greater level of distress.

Countries

United States

Contacts

CONTACTStephanie McNew
McNew.Stephanie@mayo.edu904-953-5080
PRINCIPAL_INVESTIGATORSwathi Eluri

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026